<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30592150</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1582-4934</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of cellular and molecular medicine</Title><ISOAbbreviation>J Cell Mol Med</ISOAbbreviation></Journal><ArticleTitle>Low-intensity pulsed ultrasound attenuates cardiac inflammation of CVB3-induced viral myocarditis via regulation of caveolin-1 and MAPK pathways.</ArticleTitle><Pagination><StartPage>1963</StartPage><EndPage>1975</EndPage><MedlinePgn>1963-1975</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jcmm.14098</ELocationID><Abstract><AbstractText>The aggressive immunological activity elicited by acute viral myocarditis contributes to a large amount of cardiomyocytes loss and poor prognosis of patients in clinic. Low-intensity pulsed ultrasound (LIPUS), which is an effective treatment modality for osteoarthropathy, has been recently illustrated regulating the overactive inflammatory response in various diseases. Here, we aimed to investigate whether LIPUS could attenuate coxsackievirus B3 (CVB3) infection-induced injury by coordinating the inflammatory response. Male BALB/c mice were inoculated intraperitoneally with CVB3 to establish the model of acute viral myocarditis. LIPUS treatment was given on Day 1, Day 1, 3 and Day 1, 3, 5 post-inoculation, respectively. All mice were followed up for 14 days. Day 1, 3, 5 LIPUS treatment significantly improved the survival rate, attenuated the ventricular dysfunction and ameliorated the cardiac histopathological injury of CVB3-infected mice. Western blotting analysis showed Day 1, 3, 5 LIPUS treatment decreased pro-inflammatory cytokines, increased the activation of caveolin-1 and suppressed p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK) signallings in heart tissue. RAW264.7 cells were treated with lipopolysaccharides (LPS) to simulate the augmented inflammatory response in&#xa0;vivo. LIPUS treatment on RAW264.7 inhibited the expression of pro-inflammatory cytokines, activated caveolin-1 and suppressed p38 MAPK and ERK signallings. Transfecting RAW264.7 with caveolin-1 siRNA blunted the suppression of pro-inflammatory cytokines and MAPK signallings by LIPUS treatment. Taken together, we demonstrated for the first time that LIPUS treatment attenuated the aggressive inflammatory response during acute viral myocarditis. The underlying mechanism may be activating caveolin-1 and suppressing MAPK signallings.</AbstractText><CopyrightInformation>&#xa9; 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley &amp; Sons Ltd and Foundation for Cellular and Molecular Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Sen-Min</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Ultrasound, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lian</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yuan-Zheng</ForeName><Initials>YZ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhuang</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thapa</LastName><ForeName>Saroj</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Quan-Zhi</ForeName><Initials>QZ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yi-Fan</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>The Second School of Medicine of Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jia-Feng</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0003-1748-7794</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Cell Mol Med</MedlineTA><NlmUniqueID>101083777</NlmUniqueID><ISSNLinking>1582-1838</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051242">Caveolin 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D048049">Extracellular Signal-Regulated MAP Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051242" MajorTopicYN="N">Caveolin 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048049" MajorTopicYN="N">Extracellular Signal-Regulated MAP Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName><QualifierName UI="Q000528" MajorTopicYN="Y">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="N">Myocarditis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067996" MajorTopicYN="N">RAW 264.7 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000528" MajorTopicYN="Y">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014464" MajorTopicYN="N">Ultrasonic Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069453" MajorTopicYN="N">Ultrasonic Waves</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ERK</Keyword><Keyword MajorTopicYN="N">augmented inflammatory response</Keyword><Keyword MajorTopicYN="N">caveolin-1</Keyword><Keyword MajorTopicYN="N">low-intensity pulsed ultrasound</Keyword><Keyword MajorTopicYN="N">p38 MAPK</Keyword><Keyword MajorTopicYN="N">viral myocarditis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30592150</ArticleId><ArticleId IdType="pmc">PMC6378187</ArticleId><ArticleId IdType="doi">10.1111/jcmm.14098</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yajima T, Knowlton KU. Viral myocarditis: from the perspective of the virus. Circulation. 2009;119:2615&#x2010;2624.</Citation><ArticleIdList><ArticleId IdType="pubmed">19451363</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada T, Matsumori A, Sasayama S. Therapeutic effect of anti&#x2010;tumor necrosis factor&#x2010;alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation. 1994;89:846&#x2010;851.</Citation><ArticleIdList><ArticleId IdType="pubmed">8313574</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishio R, Matsumori A, Shioi T, Ishida H, Sasayama S. Treatment of experimental viral myocarditis with interleukin&#x2010;10. Circulation. 1999;100:1102&#x2010;1108.</Citation><ArticleIdList><ArticleId IdType="pubmed">10477536</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann DL. Tumor necrosis factor and viral myocarditis: the fine line between innate and inappropriate immune responses in the heart. Circulation. 2001;103:626&#x2010;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">11156870</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchant DJ, McManus BM. Regulating viral myocarditis: allografted regulatory T cells decrease immune infiltration and viral load. Circulation. 2010;121:2609&#x2010;2611.</Citation><ArticleIdList><ArticleId IdType="pubmed">20529996</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia L, Wang Y, Chen J, Chen W. Efficacy of focused low&#x2010;intensity pulsed ultrasound therapy for the management of knee osteoarthritis: a randomized, double blind, placebo&#x2010;controlled trial. Sci Rep. 2016;6:35453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5066246</ArticleId><ArticleId IdType="pubmed">27748432</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito R, Nagase T, Tateishi T, et&#xa0;al. Outcome of low&#x2010;intensity pulsed ultrasound (LIPUS) for opening wedge high tibial osteotomy. J Orthop Trauma. 2017;31:S3.</Citation><ArticleIdList><ArticleId IdType="pubmed">28632664</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakao J, Fujii Y, Kusuyama J, et&#xa0;al. Low&#x2010;intensity pulsed ultrasound (LIPUS) inhibits LPS&#x2010;induced inflammatory responses of osteoblasts through TLR4&#x2010;MyD88 dissociation. Bone. 2014;58:17&#x2010;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">24091132</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia L, Chen J, Wang Y, Zhang Y, Chen W. Focused low&#x2010;intensity pulsed ultrasound affects extracellular matrix degradation via decreasing chondrocyte apoptosis and inflammatory mediators in a surgically induced osteoarthritic rabbit model. Ultrasound Med Biol. 2016;42:208&#x2010;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">26403700</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagao M, Tanabe N, Manaka S, et&#xa0;al. Low&#x2010;intensity pulsed ultrasound inhibits lipopolysaccharide&#x2010;induced IL&#x2010;6 and RANKL expression in osteoblasts. J Oral Sci. 2017;59:303&#x2010;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">28637991</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Junior EM, Mesquita&#x2010;Ferrari RA, Franca CM, Andreo L, Bussadori SK, Fernandes KPS. Modulating effect of low intensity pulsed ultrasound on the phenotype of inflammatory cells. Biomed Pharmacother. 2017;96:1147&#x2010;1153.</Citation><ArticleIdList><ArticleId IdType="pubmed">29191696</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanawa K, Ito K, Aizawa K, et&#xa0;al. Low&#x2010;intensity pulsed ultrasound induces angiogenesis and ameliorates left ventricular dysfunction in a porcine model of chronic myocardial ischemia. PLoS ONE. 2014;9:e104863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4128732</ArticleId><ArticleId IdType="pubmed">25111309</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindo T, Ito K, Ogata T, et&#xa0;al. Low&#x2010;intensity pulsed ultrasound enhances angiogenesis and ameliorates left ventricular dysfunction in a mouse model of acute myocardial infarction. Arterioscler Thromb Vasc Biol. 2016;36:1220&#x2010;1229.</Citation><ArticleIdList><ArticleId IdType="pubmed">27079882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata T, Ito K, Shindo T, et&#xa0;al. Low&#x2010;intensity pulsed ultrasound enhances angiogenesis and ameliorates contractile dysfunction of pressure&#x2010;overloaded heart in mice. PLoS ONE. 2017;12:e0185555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5619801</ArticleId><ArticleId IdType="pubmed">28957396</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XM, Kim HP, Song R, Choi AM. Caveolin&#x2010;1 confers antiinflammatory effects in murine macrophages via the MKK3/p38 MAPK pathway. Am J Respir Cell Mol Biol. 2006;34:434&#x2010;442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2644205</ArticleId><ArticleId IdType="pubmed">16357362</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Chen H, Cao P, et&#xa0;al. Inflammatory cytokines induce caveolin&#x2010;1/beta&#x2010;catenin signalling in rat nucleus pulposus cell apoptosis through the p38 MAPK pathway. Cell Prolif. 2016;49:362&#x2010;372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6496863</ArticleId><ArticleId IdType="pubmed">27125453</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Wang L, Dong Z, et&#xa0;al. Heparin inhibits lipopolysaccharide&#x2010;induced inflammation via inducing caveolin&#x2010;1 and activating the p38/mitogen&#x2010;activated protein kinase pathway in murine peritoneal macrophages. Mol Med Rep. 2015;12:3895&#x2010;3901.</Citation><ArticleIdList><ArticleId IdType="pubmed">25998703</ArticleId></ArticleIdList></Reference><Reference><Citation>Tourkina E, Richard M, Oates J, et&#xa0;al. Caveolin&#x2010;1 regulates leucocyte behaviour in fibrotic lung disease. Ann Rheum Dis. 2010;69:1220&#x2010;1226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2907085</ArticleId><ArticleId IdType="pubmed">20410070</ArticleId></ArticleIdList></Reference><Reference><Citation>Izadifar Z, Babyn P, Chapman D. Mechanical and biological effects of ultrasound: a review of present knowledge. Ultrasound Med Biol. 2017;43:1085&#x2010;1104.</Citation><ArticleIdList><ArticleId IdType="pubmed">28342566</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T, Fujihara S, Yamamoto&#x2010;Nagata K, Katsura T, Inubushi T, Tanaka E. Low&#x2010;intensity pulsed ultrasound reduces the inflammatory activity of synovitis. Ann Biomed Eng. 2011;39:2964&#x2010;2971.</Citation><ArticleIdList><ArticleId IdType="pubmed">21938555</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Bachem MG, Seufferlein T, Li Y, Gross HJ, Schmelz A. Low intensity pulsed ultrasound accelerates macrophage phagocytosis by a pathway that requires actin polymerization, Rho, and Src/MAPKs activity. Cell Signal. 2008;20:695&#x2010;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">18207700</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Zhao G, Shi Z, et&#xa0;al. Low&#x2010;intensity pulsed ultrasound (LIPUS) prevents periprosthetic inflammatory loosening through FBXL2&#x2010;TRAF6 ubiquitination pathway. Sci Rep. 2017;7:45779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5381120</ArticleId><ArticleId IdType="pubmed">28378753</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu L, Li C, Wang Z, Xu H, An X. Effects of the MAPK pathway and the expression of CAR in a murine model of viral myocarditis. Exp Ther Med. 2017;13:230&#x2010;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5244858</ArticleId><ArticleId IdType="pubmed">28123495</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue&#x2010;Chun L, Guang&#x2010;Yi C, Li&#x2010;Sha G, et&#xa0;al. The protective effects of ivabradine in preventing progression from viral myocarditis to dilated cardiomyopathy. Front Pharmacol. 2016;7:408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5088506</ArticleId><ArticleId IdType="pubmed">27847478</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu HF, Ding YJ, Zhang ZX, et&#xa0;al. MicroRNA21 regulation of the progression of viral myocarditis to dilated cardiomyopathy. Mol Med Rep. 2014;10:161&#x2010;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">24804616</ArticleId></ArticleIdList></Reference><Reference><Citation>Lionetti V, Fittipaldi A, Agostini S, Giacca M, Recchia FA, Picano E. Enhanced caveolae&#x2010;mediated endocytosis by diagnostic ultrasound in&#xa0;vitro. Ultrasound Med Biol. 2009;35:136&#x2010;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">18950933</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CY, Tan TH. DUSPs, to MAP kinases and beyond. Cell Biosci. 2012;2:24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3406950</ArticleId><ArticleId IdType="pubmed">22769588</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Nie S, Qu M, et&#xa0;al. The autophagic degradation of Cav&#x2010;1 contributes to PA&#x2010;induced apoptosis and inflammation of astrocytes. Cell Death Dis. 2018;9:771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6039485</ArticleId><ArticleId IdType="pubmed">29991726</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan K, Huang C, Fox J, et&#xa0;al. Elevated inflammatory response in caveolin&#x2010;1&#x2010;deficient mice with Pseudomonas aeruginosa infection is mediated by STAT3 protein and nuclear factor kappaB (NF&#x2010;kappaB). J Biol Chem. 2011;286:21814&#x2010;21825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3122236</ArticleId><ArticleId IdType="pubmed">21515682</ArticleId></ArticleIdList></Reference><Reference><Citation>Woudstra L, Juffermans LJM, van Rossum AC, Niessen HWM, Krijnen PAJ. Infectious myocarditis: the role of the cardiac vasculature. Heart Fail Rev. 2018;23:583&#x2010;595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6010496</ArticleId><ArticleId IdType="pubmed">29536322</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>